Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 80
Filtrar
Más filtros

Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Rev Assoc Med Bras (1992) ; 70(4): e2023D704, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38747880

RESUMEN

The Guidelines Project, which is an initiative of the Brazilian Medical Association, aims to combine information from the medical field to standardize how to conduct and assist in the reasoning and decision-making of doctors. The information provided by this project must be critically evaluated by the physician responsible for the conduct that will be adopted, depending on the conditions and the clinical condition of each patient.


Asunto(s)
Hipertensión , Riñón , Humanos , Hipertensión/cirugía , Riñón/inervación , Resultado del Tratamiento , Simpatectomía/métodos , Ablación por Catéter/métodos
2.
Clinics (Sao Paulo) ; 79: 100323, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38484581

RESUMEN

INTRODUCTION: Autism Spectrum Disorder (ASD) is a heterogeneous neurodevelopmental disorder, with main manifestations related to communication, social interaction, and behavioral patterns. The slight dynamics of change in the child over time require that the onset of clinical manifestations presented by the child be more valued, with the aim of stabilizing the condition. Faced with a variety of methods for diagnosing ASD, the question arises as to which method should be used. This systematic review aims to recommend the best tools to perform screening and diagnosis. METHODOLOGY: This systematic review followed the PRISMA guidelines. The databases MEDLINE, Embase, CENTRAL (Cochrane), and Lilacs were accessed, and gray and manual searches were performed. The search strategy was created with terms referring to autism and the diagnosis/broad filter. The studies were qualitatively evaluated and quantitatively. Statistical analysis was performed using Meta-diSc-2.0 software, the confidence interval was 95 %. RESULTS: The M-CHAT-R/F tool demonstrated a sensitivity of 78 % (95 % CI 0.57‒0.91) and specificity of 0.98 (95 % CI 0.88-1.00). The diagnostic tools demonstrated sensitivity and specificity respectively of: ADOS, sensitivity of 87 % (95 % CI 0.79‒0.92) and specificity 75 % (95 % CI 0.73‒0.78); ADI-R demonstrated test sensitivity of 77 % (95 % CI 0.56‒0.90) and specificity 68 % (95 % CI 0.52‒0.81), CARS test sensitivity was 89 % (95 % CI 0.78‒0.95) and specificity 79 % (95 % CI 0.65‒0.88). CONCLUSION: It is mandatory to apply a screening test, the most recommended being the M-CHAT-R/F. For diagnosis CARS and ADOS are the most recommended tools.

3.
J Bras Pneumol ; 49(6): e20230003, 2024.
Artículo en Inglés, Portugués | MEDLINE | ID: mdl-38198343

RESUMEN

OBJECTIVE: To evaluate the efficacy of wearing a mask to prevent COVID-19 infection. METHODS: This was a systematic review and meta-analysis of cohort and case-control studies, considering the best level of evidence available. Electronic databases (MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, and Clinical Trials.gov) were searched to identify studies that evaluated the effectiveness of wearing masks compared with that of not wearing them during the COVID-19 pandemic. Risk of bias and quality of evidence were assessed using the Cochrane risk of bias tool and the Grading of Recommendations Assessment, Development, and Evaluation. RESULTS: Of the 1,028 studies identified, 9 met the inclusion criteria (2 cohort studies and 7 case-control studies) and were included in the analysis. The meta-analysis using cohort studies alone showed statistically significant differences, wearing a cloth mask decreased by 21% [RD = -0.21 (95% CI, -0.34 to -0.07); I2 = 0%; p = 0,002] the risk of COVID-19 infection, but the quality of evidence was low. Regarding case-control studies, wearing a surgical mask reduced the chance of COVID-19 infection [OR = 0.51 (95% CI, 0.37-0.70); I2 = 47%; p = 0.0001], as did wearing an N95 respirator mask [OR = 0.31 (95% CI, 0.20-0.49); I2 = 0%; p = 0.00001], both with low quality of evidence. CONCLUSIONS: In this systematic review with meta-analysis, we showed the effectiveness of wearing masks in the prevention of SARS-CoV-2 infection regardless of the type of mask (disposable surgical mask, common masks, including cloth masks, or N95 respirators), although the studies evaluated presented with low quality of evidence and important biases.


Asunto(s)
COVID-19 , Humanos , COVID-19/prevención & control , Pandemias/prevención & control , SARS-CoV-2 , Estudios de Casos y Controles , Brotes de Enfermedades
4.
Obes Surg ; 34(5): 1917-1928, 2024 May.
Artículo en Inglés | MEDLINE | ID: mdl-38573390

RESUMEN

Despite the current increase in revisional bariatric surgery (RBS), data on the sustainability of weight loss remain unclear. A systematic review and meta-analysis were performed to assess weight loss outcomes in adult patients undergoing RBS with follow-up > 2 years. Twenty-eight observational studies (n = 2213 patients) were included. The %TWL was 27.2 (95%CI = 23.7 to 30.6), and there was a drop in BMI of 10.2 kg/m2 (95%CI = - 11.6 to - 8.7). The %EWL was 54.8 (95%CI = 47.2 to 62.4) but with a high risk of publication bias (Egger's test = 0.003). The overall quality of evidence was very low. Our data reinforce that current evidence on RBS is mainly based on low-quality observational studies, and further higher-quality studies are needed to support evidence-based practice.

5.
Rev Assoc Med Bras (1992) ; 69(6): e2023D696, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37377288

RESUMEN

The Guidelines Project, an initiative of the Brazilian Medical Association, aims to combine information from the medical field to standardize how to conduct, and to assist in the reasoning and decision-making of doctors. The information provided by this project must be critically evaluated by the physician responsible for the conduct that will be adopted, depending on the conditions and the clinical condition of each patient. Guideline conclusion: April 2023. Societies: Brazilian Medical Association.


Asunto(s)
Depresión , Humanos , Brasil
6.
Rev Assoc Med Bras (1992) ; 68(10): 1345-1357, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-36417631

RESUMEN

OBJECTIVE: The objective of this systematic review with meta-analysis was to evaluate the efficacy, safety, and short- and long-term tolerability of cannabidiol (CBD), as an adjunct treatment, in children and adults with Dravet syndrome (SD), Lennox-Gataut syndrome (LGS), or tuberous sclerosis complex (TSC), with inadequate control of seizures. METHODS: This systematic review was conducted through a search for scientific evidence in the Mediline/PubMed, Central Cochrane, and ClinicalTrials.gov databases until April 2022. Selected randomized clinical trials (RCTs) that presented the outcomes: reduction in the frequency of seizures and total seizures (all types), number of patients with a response greater than or equal to 50%, change in caregiver global impression of change (CGIC) (improvement ≥1 category on the initial scale), adverse events (AEs), and tolerability to treatment. This review followed Preferred Reporting Items for Systematic reviews and Meta-Analyses. RESULTS: Notably, six RCTs were included, with a total of 1,034 patients with SD, LGS, and TSC, of which 3 were open-label extension RCTs. The meta-analysis of the studies showed that the use of CBD as compared with placebo, in patients with convulsive seizures refractory to the use of medications, reduces the frequency of seizures by 33%; increases the number of patients with a reduction ≥50% in the frequency of seizures by 20%; increases the number of patients with absence of seizures by 3%; improves the clinical impression evaluated by the caregiver or patient (S/CGIC) in 21%; increases total AEs by 12%; increases serious AE by 16%; increases the risk of treatment abandonment by 12%; and increases the number of patients with transaminase elevation (≥3 times the referral) by 15%. CONCLUSIONS: This systematic review, with meta-analysis, supports the use of CBD in the treatment of patients with seizures, originated in DS, LGS, and TSC, who are resistant to the common medications, presenting satisfactory benefits in reducing seizures and tolerable toxicity.


Asunto(s)
Cannabidiol , Epilepsias Mioclónicas , Epilepsia , Síndrome de Lennox-Gastaut , Esclerosis Tuberosa , Adulto , Niño , Humanos , Anticonvulsivantes/uso terapéutico , Anticonvulsivantes/efectos adversos , Cannabidiol/uso terapéutico , Cannabidiol/efectos adversos , Epilepsias Mioclónicas/tratamiento farmacológico , Epilepsias Mioclónicas/inducido químicamente , Síndrome de Lennox-Gastaut/tratamiento farmacológico , Convulsiones/etiología , Convulsiones/inducido químicamente , Esclerosis Tuberosa/complicaciones , Esclerosis Tuberosa/tratamiento farmacológico , Esclerosis Tuberosa/inducido químicamente
7.
Clinics (Sao Paulo) ; 77: 100039, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35576869

RESUMEN

The objective of this systematic review is to provide efficacy and safety data in the application of Intra-Abdominal Hyperthermia Chemotherapy (HIPEC) and Cytoreductive Surgery (CRS) in patients with Peritoneal Pseudomyxoma (PMP) of origin in the cecal appendix. The databases Medline and Central Cochrane were consulted. Patients with PMP of origin in the cecal appendix, classified as low grade, high or indeterminate, submitted to HIPEC and CRS. The results were meta-analyzed using the Comprehensive Metanalysis software. Twenty-six studies were selected to support this review. For low-grade PMP outcome, 60-month risk of mortality, Disease-Free Survival (DFS), and adverse events was 28.8% (95% CI 25.9 to 32), 43% (95% CI 36.4 and 49.8), and 46.7% (95% CI 40.7 to 52.8); for high-grade PMP, 60-month risk of mortality, Disease-Free Survival (DFS) and adverse events was 55.9% (95% CI 51.9 to 59.6), 20.1% (95% CI 15.5 to 25.7) and 30% (95% CI 25.2 to 35.3); PMP indeterminate degree, 60-month risk of mortality, Disease-Free Survival (DFS) and adverse events was 32.6% (95% CI 30.5 to 34.7), 61.8% (95% CI 58.8 to 64.7) and 32.9% (95% CI 30.5 to 35.4). The authors conclude that the HIPEC technique and cytoreductive surgery can be applied to selected cases of patients with PMP of peritoneal origin with satisfactory results.


Asunto(s)
Neoplasias del Apéndice , Hipertermia Inducida , Neoplasias Peritoneales , Seudomixoma Peritoneal , Neoplasias del Apéndice/cirugía , Terapia Combinada , Procedimientos Quirúrgicos de Citorreducción/métodos , Humanos , Hipertermia Inducida/métodos , Quimioterapia Intraperitoneal Hipertérmica , Neoplasias Peritoneales/tratamiento farmacológico , Neoplasias Peritoneales/cirugía , Seudomixoma Peritoneal/tratamiento farmacológico , Seudomixoma Peritoneal/cirugía , Estudios Retrospectivos
8.
J Bras Pneumol ; 48(1): e20210393, 2022.
Artículo en Inglés, Portugués | MEDLINE | ID: mdl-35137874

RESUMEN

OBJECTIVE: Studies in the literature regarding the use of remdesivir to treat COVID-19 patients have shown conflicting results. This study sought to answer questions related to the use of remdesivir for the treatment of patients hospitalized with moderate to severe COVID-19. METHODS: This was a systematic review and meta-analysis including phase 3 randomized clinical trials (RCTs) and observational cohort studies selected from various databases, comparing patients hospitalized with moderate to severe COVID-19 receiving remdesivir and controls. RESULTS: A total of 207 studies were retrieved, 9 of which met the eligibility criteria and were included in the study. The meta-analysis using RCTs alone showed no statistically significant differences regarding mortality or use of mechanical ventilation/extracorporeal membrane oxygenation between remdesivir and control groups, and the quality of evidence was moderate and low, respectively. The use of remdesivir increased the recovery rate by 6% (95% CI, 3-9); p = 0.004) and the clinical improvement rate by 7% (95% CI, 1-14); p = 0.02). Additionally, no significant differences in mortality were found between remdesivir and control groups when the meta-analysis used observational cohort studies alone (risk difference = -0.01 (95% CI, -0.02 to 0.01; p = 0.32), the quality of evidence being moderate, and the risk of adverse events was 4% ([95% CI, -0.08 to 0.01]; p = 0.09). CONCLUSIONS: The use of remdesivir for the treatment of patients with moderate to severe COVID-19 had no significant impact on clinically important outcomes.


Asunto(s)
Tratamiento Farmacológico de COVID-19 , Adenosina Monofosfato/análogos & derivados , Alanina/análogos & derivados , Antivirales/uso terapéutico , Humanos , Estudios Observacionales como Asunto , SARS-CoV-2 , Resultado del Tratamiento
9.
J Bras Pneumol ; 48(4): e20220041, 2022.
Artículo en Inglés, Portugués | MEDLINE | ID: mdl-35674523

RESUMEN

OBJECTIVE: To answer questions related to the use of anticoagulants in the treatment of COVID-19 patients. METHODS: This was a systematic review and meta-analysis of phase 3 randomized controlled trials comparing the use of anticoagulants in non-hospitalized and hospitalized COVID-19 patients. We searched the following databases: MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov from their inception to January 22, 2022. The risk of bias was assessed by the Cochrane risk-of-bias tool, and the quality of evidence was assessed by the Grading of Recommendations Assessment, Development and Evaluation system. RESULTS: A total of 401 studies were initially selected. Of those, 9 met the inclusion criteria and were therefore analyzed (a total of 6,004 patients being analyzed). In non-hospitalized COVID-19 patients, no significant difference was found between post-discharge prophylactic anticoagulation and no intervention regarding venous thromboembolism or bleeding at 30 days. In hospitalized COVID-19 patients, full anticoagulation resulted in a slight reduction in thrombotic events at 30 days (risk difference, -0.03; 95% CI, -0.06 to -0.00; p = 0.04; I2 = 78%), the quality of evidence being moderate. However, no significant difference was found between full anticoagulation and no intervention regarding the risk of major bleeding, the quality of evidence being very low. No significant difference was found between intermediate- and standard-dose prophylactic anticoagulation (risk difference, -0.01; 95% CI, -0.07 to 0.06; p = 0.81; I2 = 0%), the quality of evidence being very low. CONCLUSIONS: Therapeutic anticoagulation appears to have no effect on mortality in COVID-19 patients, resulting in a slight reduction in venous thromboembolism in hospitalized patients.


Asunto(s)
Tratamiento Farmacológico de COVID-19 , Tromboembolia Venosa , Cuidados Posteriores , Anticoagulantes/uso terapéutico , Hemorragia/inducido químicamente , Humanos , Alta del Paciente , Tromboembolia Venosa/tratamiento farmacológico , Tromboembolia Venosa/prevención & control
10.
Rev Assoc Med Bras (1992) ; 66(2): 100-107, 2020 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-32428140

RESUMEN

The Guidelines Project, an initiative of the Brazilian Medical Association, aims to combine information from the medical field in order to standardize producers to assist the reasoning and decision-making of doctors. The information provided through this project must be assessed and criticized by the physician responsible for the conduct that will be adopted, depending on the conditions and the clinical status of each patient.


Asunto(s)
Anticuerpos Monoclonales Humanizados/uso terapéutico , Antineoplásicos Inmunológicos/uso terapéutico , Melanoma/tratamiento farmacológico , Neoplasias Cutáneas/tratamiento farmacológico , Adulto , Humanos , Melanoma/mortalidad , Medición de Riesgo , Factores de Riesgo , Neoplasias Cutáneas/mortalidad , Resultado del Tratamiento
11.
Rev Assoc Med Bras (1992) ; 66(12): 1615-1619, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-33331564

RESUMEN

The Guidelines Project, an initiative of the Brazilian Medical Association, aims to combine information from the medical field in order to standardize producers to assist the reasoning and decision-making of doctors. The information provided through this project must be assessed and criticized by the physician responsible for the conduct that will be adopted, depending on the conditions and the clinical status of each patient.


Asunto(s)
Urolitiasis , Brasil , Humanos , Urolitiasis/cirugía
12.
Rev Assoc Med Bras (1992) ; 66(10): 1323-1326, 2020 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-33174919

RESUMEN

The Guidelines Project, an initiative of the Brazilian Medical Association, aims to combine information from the medical field in order to standardize producers to assist the reasoning and decision-making of doctors. The information provided through this project must be assessed and criticized by the physician responsible for the conduct that will be adopted, depending on the conditions and the clinical status of each patient.


Asunto(s)
Primer Trimestre del Embarazo , Brasil , Femenino , Humanos , Embarazo , Ultrasonografía
13.
Rev Assoc Med Bras (1992) ; 65(4): 541-546, 2019 May 02.
Artículo en Inglés | MEDLINE | ID: mdl-31066807

RESUMEN

The Guidelines Project, an initiative of the Brazilian Medical Association, aims to combine information from the medical field in order to standardize producers to assist the reasoning and decision-making of doctors. The information provided through this project must be assessed and criticized by the physician responsible for the conduct that will be adopted, depending on the conditions and the clinical status of each patient.


Asunto(s)
Estimulación Encefálica Profunda/métodos , Enfermedad de Parkinson/terapia , Antiparkinsonianos/uso terapéutico , Brasil , Toma de Decisiones Clínicas , Estimulación Encefálica Profunda/efectos adversos , Humanos , Levodopa/uso terapéutico , Actividad Motora , Enfermedad de Parkinson/fisiopatología , Factores de Riesgo , Resultado del Tratamiento
14.
Rev. Assoc. Med. Bras. (1992, Impr.) ; 70(4): e2023D704, 2024. tab, graf
Artículo en Inglés | LILACS-Express | LILACS | ID: biblio-1558908

RESUMEN

SUMMARY The Guidelines Project, which is an initiative of the Brazilian Medical Association, aims to combine information from the medical field to standardize how to conduct and assist in the reasoning and decision-making of doctors. The information provided by this project must be critically evaluated by the physician responsible for the conduct that will be adopted, depending on the conditions and the clinical condition of each patient.

15.
Rev Assoc Med Bras (1992) ; 65(2): 100-104, 2019 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-30892428

RESUMEN

The Guidelines Project, an initiative of the Brazilian Medical Association, aims to combine information from the medical field in order to standardize producers to assist the reasoning and decision-making of doctors. The information provided through this project must be assessed and criticized by the physician responsible for the conduct that will be adopted, depending on the conditions and the clinical status of each patient.


Asunto(s)
Biopsia/métodos , Enfermedades Renales/patología , Riñón/patología , Laparoscopía/métodos , Femenino , Humanos , Enfermedades Renales/diagnóstico por imagen , Masculino , Guías de Práctica Clínica como Asunto , Espacio Retroperitoneal , Tomografía Computarizada de Emisión
16.
Rev Assoc Med Bras (1992) ; 65(5): 578-585, 2019 Jun 03.
Artículo en Inglés | MEDLINE | ID: mdl-31166429

RESUMEN

The Guidelines Project, an initiative of the Brazilian Medical Association, aims to combine information from the medical field in order to standardize producers to assist the reasoning and decision-making of doctors. The information provided through this project must be assessed and criticized by the physician responsible for the conduct that will be adopted, depending on the conditions and the clinical status of each patient.


Asunto(s)
Adrenalectomía/métodos , Laparoscopía/métodos , Neoplasias de las Glándulas Suprarrenales/cirugía , Adrenalectomía/normas , Humanos , Laparoscopía/normas , Peritoneo/cirugía , Reproducibilidad de los Resultados , Espacio Retroperitoneal/cirugía , Resultado del Tratamiento
17.
Rev Assoc Med Bras (1992) ; 65(11): 1329-1335, 2019 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-31800891

RESUMEN

The Guidelines Project, an initiative of the Brazilian Medical Association, aims to combine information from the medical field in order to standardize producers to assist the reasoning and decision-making of doctors. The information provided through this project must be assessed and criticized by the physician responsible for the conduct that will be adopted, depending on the conditions and the clinical status of each patient.


Asunto(s)
Litotricia/métodos , Urolitiasis/terapia , Medicina Basada en la Evidencia , Humanos , Láseres de Estado Sólido , Litotripsia por Láser , Factores de Tiempo
19.
Rev Assoc Med Bras (1992) ; 65(4): 524-529, 2019 May 02.
Artículo en Inglés | MEDLINE | ID: mdl-31066804

RESUMEN

The Guidelines Project, an initiative of the Brazilian Medical Association, aims to combine information from the medical field in order to standardize producers to assist the reasoning and decision-making of doctors. The information provided through this project must be assessed and criticized by the physician responsible for the conduct that will be adopted, depending on the conditions and the clinical status of each patient.


Asunto(s)
Cardiomiopatía Dilatada/tratamiento farmacológico , Cardiotónicos/uso terapéutico , Insuficiencia Cardíaca/tratamiento farmacológico , Simendán/uso terapéutico , Brasil , Cardiomiopatía Dilatada/mortalidad , Toma de Decisiones Clínicas , Insuficiencia Cardíaca/mortalidad , Humanos , Reproducibilidad de los Resultados , Factores de Riesgo , Resultado del Tratamiento
20.
Rev Assoc Med Bras (1992) ; 65(4): 518-523, 2019 May 02.
Artículo en Inglés | MEDLINE | ID: mdl-31066803

RESUMEN

The Guidelines Project, an initiative of the Brazilian Medical Association, aims to combine information from the medical field in order to standardize producers to assist the reasoning and decision-making of doctors. The information provided through this project must be assessed and criticized by the physician responsible for the conduct that will be adopted, depending on the conditions and the clinical status of each patient.


Asunto(s)
Embolización Terapéutica/métodos , Dolor Pélvico/terapia , Pelvis/irrigación sanguínea , Várices/terapia , Brasil , Dolor Crónico , Toma de Decisiones Clínicas , Femenino , Humanos , Reproducibilidad de los Resultados , Síndrome , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA